GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hebei Changshan Biochemical Pharmaceutical Co Ltd (SZSE:300255) » Definitions » EBITDA Margin %

Hebei Changshan Biochemical Pharmaceutical Co (SZSE:300255) EBITDA Margin % : 9.57% (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is Hebei Changshan Biochemical Pharmaceutical Co EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Hebei Changshan Biochemical Pharmaceutical Co's EBITDA for the three months ended in Mar. 2025 was ¥24.8 Mil. Hebei Changshan Biochemical Pharmaceutical Co's Revenue for the three months ended in Mar. 2025 was ¥258.7 Mil. Therefore, Hebei Changshan Biochemical Pharmaceutical Co's EBITDA margin for the quarter that ended in Mar. 2025 was 9.57%.


Hebei Changshan Biochemical Pharmaceutical Co EBITDA Margin % Historical Data

The historical data trend for Hebei Changshan Biochemical Pharmaceutical Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hebei Changshan Biochemical Pharmaceutical Co EBITDA Margin % Chart

Hebei Changshan Biochemical Pharmaceutical Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.46 12.75 7.20 -75.19 -7.81

Hebei Changshan Biochemical Pharmaceutical Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -13.80 15.24 19.48 -80.00 9.57

Competitive Comparison of Hebei Changshan Biochemical Pharmaceutical Co's EBITDA Margin %

For the Biotechnology subindustry, Hebei Changshan Biochemical Pharmaceutical Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hebei Changshan Biochemical Pharmaceutical Co's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Hebei Changshan Biochemical Pharmaceutical Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Hebei Changshan Biochemical Pharmaceutical Co's EBITDA Margin % falls into.


;
;

Hebei Changshan Biochemical Pharmaceutical Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Hebei Changshan Biochemical Pharmaceutical Co's EBITDA Margin % for the fiscal year that ended in Dec. 2024 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2024 )/Revenue (A: Dec. 2024 )
=-80.553/1030.811
=-7.81 %

Hebei Changshan Biochemical Pharmaceutical Co's EBITDA Margin % for the quarter that ended in Mar. 2025 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=24.763/258.703
=9.57 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hebei Changshan Biochemical Pharmaceutical Co  (SZSE:300255) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Hebei Changshan Biochemical Pharmaceutical Co EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Hebei Changshan Biochemical Pharmaceutical Co's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Hebei Changshan Biochemical Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
North of Yinchuan Street, Zhengding New District, Hebei, Shijiazhuang, CHN, 050800
Hebei Changshan Biochemical Pharmaceutical Co Ltd is a biotech high-tech enterprise. It is mainly engaged in the research, development, production, and sale of heparin series products. Some of the company's products are Reserpine sodium, Hyaluronic acid, Heparinoid, Heparin sodium, Tinzaparin sodium, Aspirin enteric-coated tablets, and Yihaitang.
Executives
Li Zhi Hua Executives
Wang Jun Executives
Ding Jian Wen Directors, executives
Huang Guo Sheng Executives
Gao Shu Hua Directors, executives
Chen Xi Director
Cai Hao Executives
Ji Sheng Li Directors, executives
Li Xin Securities Affairs Representative
Zhang Wei Secretary Dong
Liu Jian Executives
Zhang Zhi Ying Executives
Guo Yan Xing Supervisors

Hebei Changshan Biochemical Pharmaceutical Co Headlines

No Headlines